Novo Nordisk Shares Plunge 21% As Ozempic Are Sales Expected To Slow

Описание

Read the full story on Forbes: forbes.com/sites/tylerroush/2025/07/29/novo-nordisk-shares-plunge-21-toward-worst-day-in-40-years-as-ozempic-sales-expected-to-slow/ Subscribe to FORBES: youtube.com/user/Forbes?sub_confirmation=1 Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more: account.forbes.com/membership/?utm_source=youtube&utm_medium=display&utm_campaign=growth_non-sub_paid_subscribe_ytdescript Stay Connected Forbes newsletters: newsletters.editorial.forbes.com Forbes on Facebook: fb.com/forbes Forbes Video on Twitter: twitter.com/forbes Forbes Video on Instagram: instagram.com/forbes More From Forbes: forbes.com Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.